Cargando…

Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project

Most people living with HIV (PLHIV) established on treatment in Zambia receive multi-month prescribing and dispensing (MMSD) antiretroviral therapy (ART) and are enrolled in less-intensive differentiated service delivery (DSD) models such as Fast Track (FT), where clients collect ART every 3–6 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukumbwa-Mwenechanya, Mpande, Mubiana, Muhau, Somwe, Paul, Zyambo, Khozya, Simwenda, Maureen, Zongwe, Nancy, Kalunkumya, Estella, Mwango, Linah Kampilimba, Rabkin, Miriam, Mpesela, Felton, Chungu, Fred, Mwanza, Felix, Preko, Peter, Bolton-Moore, Carolyn, Bosomprah, Samuel, Sharma, Anjali, Morton, Khunga, Kasonde, Prisca, Mulenga, Lloyd, Lingu, Patrick, Mulenga, Priscilla Lumano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021523/
https://www.ncbi.nlm.nih.gov/pubmed/36962979
http://dx.doi.org/10.1371/journal.pgph.0000909
_version_ 1784908510160486400
author Mukumbwa-Mwenechanya, Mpande
Mubiana, Muhau
Somwe, Paul
Zyambo, Khozya
Simwenda, Maureen
Zongwe, Nancy
Kalunkumya, Estella
Mwango, Linah Kampilimba
Rabkin, Miriam
Mpesela, Felton
Chungu, Fred
Mwanza, Felix
Preko, Peter
Bolton-Moore, Carolyn
Bosomprah, Samuel
Sharma, Anjali
Morton, Khunga
Kasonde, Prisca
Mulenga, Lloyd
Lingu, Patrick
Mulenga, Priscilla Lumano
author_facet Mukumbwa-Mwenechanya, Mpande
Mubiana, Muhau
Somwe, Paul
Zyambo, Khozya
Simwenda, Maureen
Zongwe, Nancy
Kalunkumya, Estella
Mwango, Linah Kampilimba
Rabkin, Miriam
Mpesela, Felton
Chungu, Fred
Mwanza, Felix
Preko, Peter
Bolton-Moore, Carolyn
Bosomprah, Samuel
Sharma, Anjali
Morton, Khunga
Kasonde, Prisca
Mulenga, Lloyd
Lingu, Patrick
Mulenga, Priscilla Lumano
author_sort Mukumbwa-Mwenechanya, Mpande
collection PubMed
description Most people living with HIV (PLHIV) established on treatment in Zambia receive multi-month prescribing and dispensing (MMSD) antiretroviral therapy (ART) and are enrolled in less-intensive differentiated service delivery (DSD) models such as Fast Track (FT), where clients collect ART every 3–6 months and make clinical visits every 6 months. In 2019, Zambia introduced Isoniazid Preventive Therapy (IPT) with scheduled visits at 2 weeks and 1, 3, and 6 months. Asynchronous IPT and HIV appointment schedules were inconvenient and not client centered. In response, we piloted integrated MMSD/IPT in FT HIV treatment model. We implemented and evaluated a proof-of-concept project at one purposively selected high-volume facility in Lusaka, Zambia between July 2019 and May 2020. We sensitized stakeholders, adapted training materials, standard operating procedures, and screened adults in FT for TB as per national guidelines. Participants received structured TB/IPT education, 6-month supply of isoniazid and ART, aligned 6(th) month IPT/MMSD clinic appointment, and phone appointments at 2 weeks and months 1–5 following IPT initiation. We used descriptive statistics to characterize IPT completion rates, phone appointment keeping, side effect frequency and Fisher’s exact test to determine variation by participant characteristics. Key lessons learned were synthesized from monthly meeting notes. 1,167 clients were screened with 818 (70.1%) enrolled, two thirds (66%) were female and median age 42 years. 738 (90.2%) completed 6-month IPT course and 66 (8.1%) reported IPT-related side effects. 539 clients (65.9%) attended all 7 telephone appointments. There were insignificant differences of outcomes by age or sex. Lessons learnt included promoting project ownership, client empowerment, securing supply chain, adapting existing processes, and cultivating collaborative structured learning. Integrating multi-month dispensing and telephone follow up of IPT into the FT HIV treatment model is a promising approach to scaling-up TB preventive treatment among PLHIV, although limited by barriers to consistent phone access.
format Online
Article
Text
id pubmed-10021523
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100215232023-03-17 Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project Mukumbwa-Mwenechanya, Mpande Mubiana, Muhau Somwe, Paul Zyambo, Khozya Simwenda, Maureen Zongwe, Nancy Kalunkumya, Estella Mwango, Linah Kampilimba Rabkin, Miriam Mpesela, Felton Chungu, Fred Mwanza, Felix Preko, Peter Bolton-Moore, Carolyn Bosomprah, Samuel Sharma, Anjali Morton, Khunga Kasonde, Prisca Mulenga, Lloyd Lingu, Patrick Mulenga, Priscilla Lumano PLOS Glob Public Health Research Article Most people living with HIV (PLHIV) established on treatment in Zambia receive multi-month prescribing and dispensing (MMSD) antiretroviral therapy (ART) and are enrolled in less-intensive differentiated service delivery (DSD) models such as Fast Track (FT), where clients collect ART every 3–6 months and make clinical visits every 6 months. In 2019, Zambia introduced Isoniazid Preventive Therapy (IPT) with scheduled visits at 2 weeks and 1, 3, and 6 months. Asynchronous IPT and HIV appointment schedules were inconvenient and not client centered. In response, we piloted integrated MMSD/IPT in FT HIV treatment model. We implemented and evaluated a proof-of-concept project at one purposively selected high-volume facility in Lusaka, Zambia between July 2019 and May 2020. We sensitized stakeholders, adapted training materials, standard operating procedures, and screened adults in FT for TB as per national guidelines. Participants received structured TB/IPT education, 6-month supply of isoniazid and ART, aligned 6(th) month IPT/MMSD clinic appointment, and phone appointments at 2 weeks and months 1–5 following IPT initiation. We used descriptive statistics to characterize IPT completion rates, phone appointment keeping, side effect frequency and Fisher’s exact test to determine variation by participant characteristics. Key lessons learned were synthesized from monthly meeting notes. 1,167 clients were screened with 818 (70.1%) enrolled, two thirds (66%) were female and median age 42 years. 738 (90.2%) completed 6-month IPT course and 66 (8.1%) reported IPT-related side effects. 539 clients (65.9%) attended all 7 telephone appointments. There were insignificant differences of outcomes by age or sex. Lessons learnt included promoting project ownership, client empowerment, securing supply chain, adapting existing processes, and cultivating collaborative structured learning. Integrating multi-month dispensing and telephone follow up of IPT into the FT HIV treatment model is a promising approach to scaling-up TB preventive treatment among PLHIV, although limited by barriers to consistent phone access. Public Library of Science 2023-03-08 /pmc/articles/PMC10021523/ /pubmed/36962979 http://dx.doi.org/10.1371/journal.pgph.0000909 Text en © 2023 Mukumbwa-Mwenechanya et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mukumbwa-Mwenechanya, Mpande
Mubiana, Muhau
Somwe, Paul
Zyambo, Khozya
Simwenda, Maureen
Zongwe, Nancy
Kalunkumya, Estella
Mwango, Linah Kampilimba
Rabkin, Miriam
Mpesela, Felton
Chungu, Fred
Mwanza, Felix
Preko, Peter
Bolton-Moore, Carolyn
Bosomprah, Samuel
Sharma, Anjali
Morton, Khunga
Kasonde, Prisca
Mulenga, Lloyd
Lingu, Patrick
Mulenga, Priscilla Lumano
Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project
title Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project
title_full Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project
title_fullStr Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project
title_full_unstemmed Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project
title_short Integrating isoniazid preventive therapy into the fast-track HIV treatment model in urban Zambia: A proof-of -concept pilot project
title_sort integrating isoniazid preventive therapy into the fast-track hiv treatment model in urban zambia: a proof-of -concept pilot project
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021523/
https://www.ncbi.nlm.nih.gov/pubmed/36962979
http://dx.doi.org/10.1371/journal.pgph.0000909
work_keys_str_mv AT mukumbwamwenechanyampande integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT mubianamuhau integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT somwepaul integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT zyambokhozya integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT simwendamaureen integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT zongwenancy integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT kalunkumyaestella integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT mwangolinahkampilimba integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT rabkinmiriam integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT mpeselafelton integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT chungufred integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT mwanzafelix integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT prekopeter integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT boltonmoorecarolyn integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT bosomprahsamuel integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT sharmaanjali integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT mortonkhunga integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT kasondeprisca integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT mulengalloyd integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT lingupatrick integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject
AT mulengapriscillalumano integratingisoniazidpreventivetherapyintothefasttrackhivtreatmentmodelinurbanzambiaaproofofconceptpilotproject